Ahed Makhoul, MD
Hospice and Palliative Medicine · Cleveland, OHNPI 1316301302
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $747 of the $1,084 with a category attached, or 68.9%. 8 manufacturers reported payments, led by Johnson & Johnson at 43.1% of the total. 2025 is the largest year on record at $845, more than ten times the $75 reported in 2020.
Across 11 payments — averaging $98.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$467
- Regeneron Healthcare Solutions, Inc.$125
- Amgen$117
- Incyte Corporation$97
- Seagen Inc.$88
- Medtronic$75
- plus $114 from 2 others
What the payments were for
- Grants$757%
- Food & beverage$74769%
- Education$26224%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $467 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Amgen | 1 | $117 |
| Incyte Corporation | 1 | $97 |
| Seagen Inc. | 1 | $88 |
| Medtronic | 1 | $75 |
| Astellas Pharma US Inc | 1 | $75 |
| Sanofi | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,084 in reported general payments places this provider in the 85th percentile of 88 hospice and palliative medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 24 | $17,194 |
| OxycontinOxycodone Hcl | 20 | $15,445 |
| Buprenorphine | 44 | $9,484 |
| Ondansetron Hcl | 56 | $9,301 |
| Oxycodone Hcl | 424 | $7,567 |
| Fentanyl | 84 | $7,482 |
| ButransBuprenorphine | 12 | $6,451 |
| Lidocaine | 33 | $2,989 |
| Pregabalin | 129 | $2,580 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 24 | $2,315 |
| Gabapentin | 198 | $1,994 |
| Duloxetine Hcl | 130 | $1,822 |
| Morphine Sulfate ErMorphine Sulfate | 67 | $1,623 |
| Mirtazapine | 72 | $1,015 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 42 | $991 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Cleveland
- Bassam EstfanCleveland$20K
- John LeeCleveland$4K
- Ana Siu ChangCleveland$1K
- Mona GuptaCleveland$668
- Alexander BeylinsonCleveland$495
- Joseph ParenteauCleveland$269
- Allison EarlyCleveland$265
- Kevin LiuCleveland$161
- Candace LeighCleveland$133
- Joanna ChenCleveland$132
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.